BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.300
0.00 (0.00%)
Oct 5, 2025, 1:37 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 60.05 million as of October 7, 2025. Its market cap has decreased by -69.85% in one year.
Market Cap
60.05M
Enterprise Value
7.64M
Revenue
58.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.30
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 60.05M, an increase of 36,734.06%. That is a compound annual growth rate of 37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2025 | 60.05M | -29.81% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | 192.39M | 108.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 75.93B |
| Danel (Adir Yeoshua) | 3.00B |
| Kamada | 1.33B |
| Bait Bakfar | 974.87M |
| BrainsWay | 961.20M |
| SofWave Medical | 943.38M |
| Ilex Medical | 747.81M |
| Novolog (Pharm-Up 1966) | 661.07M |